Neuland Laboratories share price
You have to be logged in to add this to Watchlist.Neuland Laboratories is trading -0.21% lower at Rs 14,872.95 as compared to its last closing price. Neuland Laboratories has been trading in the price range of 15,466.90 & 14,703.00. Neuland Laboratories has given 181.68% in this year & 1.63% in the last 5 days.
Neuland Laboratories has TTM P/E ratio 56.82 as compared to the sector P/E of 33.29.There are 2 analysts who have initiated coverage on Neuland Laboratories. There are 1 analysts who have given it a strong buy rating & 1 analysts have given it a buy rating. 0 analysts have given the stock a sell rating.
The company posted a net profit of 32.84 Crores in its last quarter.
Listed peers of Neuland Laboratories include Aurobindo Pharma (1.04%), Pfizer (0.36%), Neuland Laboratories (-0.21%) etc.
Neuland Laboratories has a 67.36% public holding.The Mutual Fund holding in Neuland Laboratories was at 4.04% in 30 Sep 2024. The MF holding has decreased from the last quarter. The FII holding in Neuland Laboratories was at 26.46% in 30 Sep 2024. The FII holding has increased from the last quarter.
Neuland Laboratories share price range
|
| ||||
|
| ||||
Neuland Laboratories share Key Metrics
| Market Cap ( ₹ Cr.) | 19,122.89 | ||||||||||||||||||
|
|
Technical Trends
Long TermConsiders price movement over the last 6 months
Short TermConsiders price movement over the last 1-2 weeks
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Neuland Laboratories Corporate actions
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
| 06-Nov-24 | Quarterly Results |
| 01-Aug-24 | Quarterly Results |
| 10-May-24 | Audited Results & Final Dividend |
| 08-Feb-24 | Quarterly Results |
| 07-Nov-23 | Quarterly Results |
| 03-Aug-23 | Quarterly Results |
| 11-May-23 | Audited Results & Final Dividend |
| 13-Feb-23 | Quarterly Results |
| 10-Nov-22 | Quarterly Results |
| 03-Aug-22 | Quarterly Results |
| Meeting Date | Announcement On | Purpose |
| 31-Jul-24 | 10-May-24 | AGM |
| 27-Jul-23 | 11-May-23 | AGM |
| 02-Aug-22 | 17-Jun-22 | AGM |
| 07-Jul-21 | 07-Jun-21 | AGM |
| Announcement On | Record Date | Ex-Dividend | Dividend Value |
| 10-May-24 | - | 12-Jul-24 | 14 |
| 11-May-23 | - | 11-Jul-23 | 10 |
| 10-May-22 | 15-Jul-22 | 14-Jul-22 | 5 |
| 11-May-21 | - | 29-Jun-21 | 3 |
FAQs about Neuland Laboratories share price
Neuland Laboratories is trading at 14872.95 as on Mon Nov 25 2024 10:19:14. This is -0.21% lower as compared to its previous closing price of 14904.25.
The market capitalization of Neuland Laboratories is 19122.89 Cr as on Mon Nov 25 2024 10:19:14.
The average broker rating on Neuland Laboratories is Strong Buy. The breakup of analyst rating is given below -
- 1 analysts have given a strong buy rating
- 1 analysts have given a buy rating
- 0 analysts have given a hold rating
- 0 analysts have given a sell rating
- 0 analysts have given a strong sell rating
The 52 wk high for Neuland Laboratories is 16544.75 whereas the 52 wk low is 4928.00
Neuland Laboratories can be analyzed on the following key metrics -
- TTM P/E: 56.82
- Sector P/E: 33.29
- Dividend Yield: 0.09%
- D/E ratio: 0.08
Neuland Laboratories reported a net profit of 300.08 Cr in 2024.
Neuland Laboratories Quick Links
Neuland Laboratories Dividend Neuland Laboratories Bonus Neuland Laboratories News Neuland Laboratories AGM Neuland Laboratories Rights Neuland Laboratories Splits Neuland Laboratories Board Meetings Neuland Laboratories Key Metrics Neuland Laboratories Shareholdings Neuland Laboratories Profit Loss Neuland Laboratories Balance Sheet Neuland Laboratories Cashflow Neuland Laboratories Q1 Results Neuland Laboratories Q2 Results Neuland Laboratories Q3 Results Neuland Laboratories Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks